Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transplant Cell Ther. 2020 Oct 11;27(1):84.e1–84.e5. doi: 10.1016/j.bbmt.2020.10.008

Figure 1.

Figure 1.

Neutrophil engraftment in the foscarnet and no foscarnet groups. The incidence of neutrophil engraftment at day 42 was 96% (95% CI, 83% to 100%) in the foscarnet group and 75% in the control group (95% CI, 64% to 85%).